KORU Medical Systems, Inc. has announced a significant leadership transition as Linda Tharby, the current President and Chief Executive Officer, plans to retire effective June 30, 2026. In a strategic move to ensure continuity, Adam Kalbermatten has been appointed as the new President, effective March 15, 2026, and will take over as CEO on July 1, 2026. This transition is designed to facilitate an orderly leadership change while maintaining the company's operational stability. Tharby will continue to serve in an advisory capacity until the end of 2026, ensuring her expertise remains available during this critical period. Under the terms of her separation agreement, Tharby will receive her regular salary and bonuses for the duration of her advisory role, with specific provisions for her equity awards. Kalbermatten's new employment agreement includes a base salary of $450,000, increasing to $525,000 upon his transition to CEO, along with performance-based bonuses and long-term incentive awards. This leadership change is expected to positively impact the company's strategic direction and operational execution as it navigates future growth opportunities.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.